Analyst Ratings for Sutro Biopharma (STRO)
STRO Rating Summary
STRO Price Target Summary
- Highest: $60.00 (Wedbush)
- Lowest: $4.00 (Jefferies)
- Average: $40.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$40.50 (+71.8%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
Rating Score: 8.8 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/11/2026 | Truist Securities | Supawat Thongthip | New Coverage | Buy (N/A) |
50.00 (N/A) |
26.09 (23.57) |
-9.66% | Details |
| 5/28/2026 | Barclays | Lukas Shumway | New Coverage | Overweight (N/A) |
56.00 (N/A) |
27.38 (23.57) |
-13.92% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
